News
                            stdClass Object
(
    [post_id] => 1291
    [category_id] => 4
    [id] => 4
    [language_code] => en
    [title] => News
    [description] => News
    [slug] => news
    [meta_title] => News
    [meta_description] => News
    [meta_keyword] => News
    [content] => 
    [parent_id] => 0
    [thumbnail] => 
    [banner] => trang_chu/tt_xn/gioi_thieu_ttxn_gentis_(10).jpg
    [is_featured] => 
    [files] => 
    [style] => 
    [class] => 
    [type] => post
    [order] => 1
    [is_status] => 1
    [created_time] => 2019-08-24 10:39:48
    [updated_time] => 2021-09-07 13:05:32
    [created_by] => 
    [updated_by] => 
    [ratting] => 
    [retionship] => 
    [question] => 
    [url_video] => 
    [link] => 
    [i_con] => 
)
1                        

Created date : 24-03-2025
Updated date: 15-04-2025
Author: Gentis
GENTIS is a pioneer in the field of genetic analysis, providing the best and most advanced services and tests to customers and partners with the goal of enhancing the physical and intellectual well-being of the Vietnamese people — including PGT-M testing.
Main content

PGT-M (Preimplantation Genetic Testing for Monogenic diseases) is a genetic screening test performed on embryos to identify and select embryos that do not carry disease-causing genetic mutations inherited from the parents. This test is typically recommended for couples who are carriers of mutations linked to genetic disorders and wish to prevent passing these conditions on to their children. As it is performed before embryo transfer, this early screening method helps avoid the risk of children being born with genetic diseases and reduces the need for pregnancy termination due to severe genetic abnormalities.

To ensure accuracy and compatibility with GENTIS' testing protocols, and to protect customer rights during the PGT-M testing process, we issue the following recommendations regarding the submission of genetic test results before performing PGT-M:

  • In cases where genetic test results are provided from a family member affected by the condition (e.g., children, siblings, etc.), mutation confirmation in the couple intending to undergo PGT-M is MANDATORY.
  • In cases where genetic test results are provided from the couple intending to undergo PGT-M:
  • If the test was performed at GENTIS: The result is accepted for use in PGT-M, and GENTIS takes full responsibility for the accuracy of this result.
  • If the test was performed at another laboratory: Sanger sequencing data must be provided, or it is recommended that mutation confirmation be redone at GENTIS.

Why does GENTIS require mutation confirmation in parents before performing PGT-M?

  • Commitment to quality and medical responsibility: GENTIS is fully accountable for the results of tests it performs. We cannot guarantee the accuracy of tests conducted by third parties.
  • The genetic test results directly impact the PGT-M process and its outcomes.
  • Ensuring customer rights during PGT-M testing: Confirming the mutation in the couple allows doctors to make appropriate decisions regarding PGT-M, preventing scenarios where patients undergo an IVF cycle but cannot proceed with PGT-M due to inadequate testing.

Important Recommendation

If you are considering PGT-M testing, we strongly recommend that it be performed directly at GENTIS to ensure the highest level of accuracy, consistency, and compatibility with your treatment plan.

Contact GENTIS' expert team to have all your questions answered before proceeding with testing.
GENTIS is committed to providing accurate, safe, and optimized testing services — ensuring a complete and satisfying experience for our clients.

GENTIS HOTLINE: 1800 2010
Website: gentis.com.vn

Có thể bạn quan tâm
ĐĂNG KÝ DỊCH VỤ TẠI GENTIS
Cảm ơn Quý khách đã tin tưởng sử dụng dịch vụ của GENTIS,
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!